PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise ...

The NHS has announced the launch of a new initiative aimed at identifying pancreatic cancer in its earliest stages. The three ...

Biocartis Group of Companies (Biocartis) has announced the appointment of Ben Svarczkopf as its new Senior Vice President ...

eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derived ...

Teva’s experimental anti-PD1-IL2 ATTENUKINE therapy is designed to selectively deliver interleukin-2 to PD-1-expressing T ...

A new investigational treatment has shown strong and lasting responses in multiple myeloma patients with extramedullary ...

EDX Medical Group has entered into an agreement with Spire Healthcare Group to advance diagnostic innovations aimed at ...

Zusduri, which is delivered directly into the bladder in an out-patient procedure, is now the first and only medication approved by the US regulator to treat adults with recurrent low-grade ...

In a move to progress treatment efficacy, oncologists widely agree that, in the future, cancer treatments will become ...

Kallikor has announced the appointment of Chris Brett as its new Chief Technology and Product Officer. Brett holds more than ...

Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025). The ...

The European Migraine and Headache Alliance (EMHA) has urged EU policymakers to include migraine in the forthcoming ...